Ma is tanultam valamit
382 - Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Epizódok
382-
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Meghallgatva
381-
Ep. 371 - Moving faster at the academia-industry interface
Meghallgatva
380-
Ep. 370 - Calmer waters for FDA; Servier, Lilly deals
Meghallgatva
379-
Ep. 369 - ASCO advances, China innovation & U.S. science under threat
Meghallgatva
378-
